Similar findings were also observed in case 29, a patient with compound heterozygous c.662A>T, c.919G>A, and c.2039G>A mutations in FSHR who also developed ovarian hyperstimulation syndrome during ovarian stimulation (29), but no experimental evidence regarding the impact of these mutations on receptor functions was available. The gene discussed is FSHR; the disease is ovarian hyperstimulation syndrome.